Stop the growth different mesylate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy18

K562 Cells Philadelphia Chromosome Cell Line, Tumor Cells, Cultured Chromosomes, Human, Pair 9 Neoplastic Stem Cells Myeloid Progenitor Cells Cell Line Fibroblasts Orbit Skin Tumor Cells, Cultured Bone Marrow HL-60 Cells Stromal Cells Hematopoietic Stem Cells Brain Bone Marrow Cells

Organisms5

Mice, SCID Mice, Inbred BALB C Escherichia coli Mice, Nude Rats, Sprague-Dawley

Diseases43

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Leukemia, Myeloid, Chronic-Phase Hypopigmentation Hypereosinophilic Syndrome Blast Crisis Gastrointestinal Neoplasms Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Philadelphia Chromosome Mastocytosis, Systemic Dermatofibrosarcoma Fibromatosis, Aggressive Lichenoid Eruptions Nausea Leukemia, Myeloid, Accelerated Phase Recurrence Primary Myelofibrosis Neoplasm, Residual Disease Progression Vomiting Neutropenia Histiocytoma, Malignant Fibrous Scleroderma, Systemic Thrombocytopenia Graves Ophthalmopathy Fibrosis Anorexia Spinal Cord Neoplasms Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia Pulmonary Fibrosis Neoplasm Metastasis Nerve Sheath Neoplasms Myeloproliferative Disorders Disease Models, Animal Bone Neoplasms Chromosome Aberrations Peritoneal Neoplasms Peripheral Nervous System Diseases Skin Neoplasms Carcinoma, Small Cell Brain Neoplasms

Chemicals and Drugs101

Benzamides Piperazines Pyrimidines Pregnatrienes Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Codon, Terminator Receptor, Platelet-Derived Growth Factor alpha Ketones Furans Protein Kinase Inhibitors Receptor, Platelet-Derived Growth Factor beta Protein-Tyrosine Kinases Ergoloid Mesylates Deferoxamine Proto-Oncogene Proteins c-abl Mesylates Pergolide Fenoldopam Enzyme Inhibitors Pefloxacin Benzoxazines Delavirdine Codon, Nonsense Receptors, Platelet-Derived Growth Factor Tubulin Modulators Pralidoxime Compounds Quinolizines Nelfinavir Naphthalenes Gabexate RNA, Messenger Proto-Oncogene Proteins c-sis Peptide Termination Factors Antimitotic Agents Morpholines Pyrroles Cannabinoid Receptor Agonists Ergolines Dihydroergotoxine Cannabinoids Bromocriptine Harringtonines mRNA Cleavage and Polyadenylation Factors Dihydroergotamine Codon Doxazosin Rifabutin Indoles Interferon-alpha Receptors, Glucocorticoid Hydroxyurea Dexamethasone Thiazoles STAT5 Transcription Factor Receptors, Cannabinoid Phentolamine Platelet-Derived Growth Factor Lipid Peroxides Piperidines Stem Cell Factor Receptor, Cannabinoid, CB1 Adrenergic alpha-Antagonists Free Radical Scavengers Cannabinoid Receptor Antagonists Antiemetics Oncogene Proteins, Fusion Pyrazoles Milk Proteins Camptothecin Topotecan Naphthyridines Dronabinol Neoplasm Proteins Affinity Labels Antigens, CD34 Antineoplastic Agents, Phytogenic ATP-Binding Cassette Transporters Iron Chelating Agents Lactams, Macrocyclic Cyclohexanols Benzoquinones Triamcinolone Acetonide Bleomycin src-Family Kinases P-Glycoprotein Drug Combinations HIV Protease Inhibitors Cytarabine Deoxycytidine Proto-Oncogene Proteins c-bcl-2 Pyridines Receptors, Steroid Cannabinoid Receptor Modulators Receptors, Granulocyte Colony-Stimulating Factor DNA-Binding Proteins Tumor Markers, Biological Proto-Oncogene Proteins c-akt Anti-HIV Agents Fluorodeoxyglucose F18

Analytical, Diagnostic and Therapeutic Techniques and Equipment46

Cytogenetic Analysis Treatment Outcome Remission Induction Drug Approval Administration, Oral Disease-Free Survival Drug Administration Schedule Reverse Transcriptase Polymerase Chain Reaction DNA Mutational Analysis Survival Analysis Treatment Failure Prognosis Antineoplastic Combined Chemotherapy Protocols Salvage Therapy Follow-Up Studies In Situ Hybridization, Fluorescence Survival Rate Blotting, Western Retreatment Maximum Tolerated Dose Polymerase Chain Reaction Immunohistochemistry Chromatography, High Pressure Liquid Blood Cell Count Inhibitory Concentration 50 Combined Modality Therapy Neoadjuvant Therapy Area Under Curve Clinical Trials as Topic Transplantation, Homologous Infusions, Intravenous Double-Blind Method Disease Models, Animal Positron-Emission Tomography Cloning, Molecular Drug Screening Assays, Antitumor Pedigree Hematopoietic Stem Cell Transplantation Drug Therapy, Combination Transfection Sequence Analysis, DNA Prospective Studies Drug Stability Mass Spectrometry Karyotyping Gene Expression Profiling

Psychiatry and Psychology2

Smoking Cessation Inhibition (Psychology)

Phenomena and Processes45

Codon, Terminator Genes, abl Drug Resistance, Neoplasm Philadelphia Chromosome Dose-Response Relationship, Drug Mutation Codon, Nonsense Peptide Chain Termination, Translational Time Factors Base Sequence Apoptosis Phosphorylation Cell Proliferation Codon Drug Synergism Amino Acid Sequence Frameshift Mutation Chromosomes, Human, Pair 9 Signal Transduction Point Mutation Cell Survival Maximum Tolerated Dose Gene Expression Regulation, Leukemic Cell Division Blood Cell Count Inhibitory Concentration 50 Protein Biosynthesis Area Under Curve Exons G0 Phase Gene Expression Drug Interactions Transcription, Genetic Open Reading Frames Chromosome Aberrations Down-Regulation Protein Structure, Tertiary Gene Expression Regulation, Neoplastic Transfection Kinetics Tissue Distribution Molecular Structure Pseudogenes Cell Death Cell Cycle

Disciplines and Occupations2

Cytogenetics Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval United States Food and Drug Administration

Technology, Industry, Agriculture1

Information Science5

Base Sequence Molecular Sequence Data Amino Acid Sequence Survival Rate Phonetics

Health Care11

Treatment Outcome Disease-Free Survival United States Food and Drug Administration Survival Analysis Treatment Failure Follow-Up Studies Survival Rate Area Under Curve Clinical Trials as Topic Double-Blind Method Prospective Studies

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care

Benzamides Piperazines Pyrimidines Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Pregnatrienes Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Codon, Terminator Receptor, Platelet-Derived Growth Factor alpha Ketones Furans Protein Kinase Inhibitors Leukemia, Myeloid, Chronic-Phase Receptor, Platelet-Derived Growth Factor beta Hypopigmentation Hypereosinophilic Syndrome Blast Crisis Cytogenetic Analysis Genes, abl Drug Resistance, Neoplasm Protein-Tyrosine Kinases Ergoloid Mesylates Deferoxamine Proto-Oncogene Proteins c-abl Gastrointestinal Neoplasms K562 Cells Treatment Outcome Mesylates Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Pergolide Philadelphia Chromosome Fenoldopam Enzyme Inhibitors Remission Induction Drug Approval Pefloxacin Dose-Response Relationship, Drug Mutation Benzoxazines Delavirdine Codon, Nonsense Mastocytosis, Systemic Dermatofibrosarcoma Receptors, Platelet-Derived Growth Factor Tubulin Modulators Administration, Oral Pralidoxime Compounds Quinolizines Nelfinavir Naphthalenes Cell Line, Tumor Gabexate Fibromatosis, Aggressive RNA, Messenger Proto-Oncogene Proteins c-sis Peptide Chain Termination, Translational Time Factors Base Sequence Peptide Termination Factors Molecular Sequence Data Antimitotic Agents Morpholines Disease-Free Survival Drug Administration Schedule Pyrroles Cannabinoid Receptor Agonists Apoptosis Ergolines Dihydroergotoxine Cannabinoids Lichenoid Eruptions Bromocriptine Phosphorylation Nausea Harringtonines Cell Proliferation United States Food and Drug Administration mRNA Cleavage and Polyadenylation Factors Dihydroergotamine Leukemia, Myeloid, Accelerated Phase Codon Drug Synergism Doxazosin Rifabutin Indoles Reverse Transcriptase Polymerase Chain Reaction Cells, Cultured DNA Mutational Analysis Recurrence Survival Analysis Interferon-alpha Primary Myelofibrosis Amino Acid Sequence Treatment Failure Neoplasm, Residual Prognosis Frameshift Mutation Disease Progression

No FAQ available that match "stop the growth different mesylate"